Borderline clear cell adenofibroma with extensive hemorrhagic necrosis

Bell, 1985, Benign and borderline clear cell adenofibromas of the ovary, Cancer., 56, 2922, 10.1002/1097-0142(19851215)56:12<2922::AID-CNCR2820561233>3.0.CO;2-L Roth, 1984, Ovarian clear cell adenofibromatous tumors: benign, of low malignant potential, and associated with invasive clear cell carcinoma, Caner., 53, 1156, 10.1002/1097-0142(19840301)53:5<1156::AID-CNCR2820530522>3.0.CO;2-2 Yamamoto, 2008, Clear-cell adenofibroma can be a clonal precursor for clear-cell adenocarcinoma of the ovary: a possible alternative ovarian clear-cell carcinogenic pathway, J Pathol., 216, 103 Yamamoto, 2007, Clear cell adenocarcinoma associated with clear cell ad-enofibromatous components: a subgroup of ovarian clear cell adenocarcinoma with distinct clini-copathologic characteristics, Am J Surg Pathol., 31, 999, 10.1097/01.pas.0000249449.13466.3c Veras, 2009, Cystic and adenofibromatous clear cell carcinomas of the ovary, distinctive tumors that differ in their pathogenesis and behavior: a clinicopathologic analysis of 122 cases, Am J Surg Pathol., 33, 844, 10.1097/PAS.0b013e31819c4271 Yamamoto, 2009, An allelotype analysis indicating the presence of two distinct ovarian clear-cell carcinogenic pathways: endometriosis-associated pathway vs. clear-cell adenofibroma-associated pathway, Virchows Arch., 455, 261, 10.1007/s00428-009-0816-9 Yamamoto, 2009, Aberrant expression of p27 (Kip1)-interacting cell-cycle regulatory proteins in ovarian clear cell carcinomas and their precursors with special consideration of two distinct multistage clear cell carcinogenetic pathways, Virchows Arch., 455, 413, 10.1007/s00428-009-0844-5